28.10.2026 
Redaktion
AL-S Pharma appoints Harry Welten as CEO
Bildnachweis: AL-S Pharma.Swiss biotechnology company AL-S Pharma AG has appointed Harry Welten as chief executive officer (CEO). He succeeds Michael Salzmann, Ph.D., and will lead the company as it prepares to advance its lead candidate AP-101 into a confirmatory Phase 3 clinical trial, which it ai

